• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareHealthcare Equipment & SuppliesSigyn Therapeutics
    Picture of Sigyn Therapeutics logo

    SIGY — Sigyn Therapeutics Share News

    $0.040.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      $0.06m
    • Enterprise Value
      $2.78m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SIGY Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SIGY Dividends
    • Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation

      07/05/2026 13:33
    • Brief: Sigyn Therapeutics Appoints Ajay Verma To Its Scientific Advisory Board

      31/03/2022 14:07
    • Brief: Reign Sapphire Corp. Provides Shareholder Update And Expectations For 2018

      03/04/2018 13:08
    • Brief: Reign Sapphire Says Expects To Release Reign Coin's White Paper Later This Month

      07/02/2018 14:00
    • Brief: Reign Sapphire Corporation signs binding letter of intent to acquire 100% of the assets of custom jewelry company Coordinates Collection Inc

      07/11/2016 13:00

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.